{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:10:24Z","timestamp":1758874224904},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T00:00:00Z","timestamp":1112054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Rearrangements in the 11q23 region, the site of the mixed lineage leukaemia (<jats:italic>MLL<\/jats:italic>) gene, are found in both childhood acute myeloid (AML) and lymphoblastic (ALL) leukaemia. We studied the <jats:italic>in vitro<\/jats:italic> drug resistance by the fluorometric microculture cytotoxicity assay (FMCA) in 132 children with AML and 178 children with ALL (aged 0\u201317\u2003years). In AML, children with t(9;11) (<jats:italic>n<\/jats:italic>\u2003=\u200310) were significantly more sensitive to cytarabine (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001) and doxorubicin (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7005) than non\u201011q23 rearranged patients (<jats:italic>n<\/jats:italic>\u2003=\u2003108). Children with other 11q23 rearrangements (<jats:italic>n<\/jats:italic>\u2003=\u200314) differed less from non\u2010rearranged children. The \u2018AML\u2010profile\u2019 common to all three groups included relative resistance to glucocorticoids and vincristine. In ALL, children with 11q23 rearrangement (<jats:italic>n<\/jats:italic>\u2003=\u200322) were significantly more sensitive to cytarabine (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7026) than children without 11q23 rearrangement (<jats:italic>n<\/jats:italic>\u2003=\u2003156), also after stratification for white blood cell count. In conclusion, the findings indicate that the cellular drug resistance is correlated to both the cell lineage and the type of 11q23 rearrangement. High cellular sensitivity to cytarabine and doxorubicin might explain the excellent treatment results in children with AML and t(9;11). The present study supports the strategy of contemporary protocols to include high\u2010dose cytarabine in the treatment of 11q23\u2010positive patients both in AML and ALL.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05433.x","type":"journal-article","created":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T14:35:41Z","timestamp":1112798141000},"page":"189-198","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cellular drug sensitivity in <i>MLL<\/i>\u2010rearranged childhood acute leukaemia is correlated to partner genes and cell lineage"],"prefix":"10.1111","volume":"129","author":[{"given":"J.","family":"Palle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. M.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hellebostad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. G.","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"L\u00f6nnerholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Nordic Society for Paediatric Haematology and Oncology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,6]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng765"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.7.2870.bloodjournal8772870"},{"key":"e_1_2_17_4_1","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene M.C.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3221"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90103.x"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04349.x"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00286-X"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04442.x"},{"key":"e_1_2_17_10_1","first-page":"2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade D.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401961"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.107"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600787"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-19022-3_16"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.333"},{"key":"e_1_2_17_16_1","first-page":"1224","article-title":"Different cellular drug resistance profiles in childhood lymphoblastic and non\u2010lymphoblastic leukemia: a preliminary report","volume":"8","author":"Kaspers G.J.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.7.2723"},{"key":"e_1_2_17_18_1","first-page":"249","volume-title":"Drug Resistance in Oncology","author":"Larsson R.","year":"1997"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(05)80316-8"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500204"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04418.x"},{"volume-title":"An International System for Human Cytogenetic Nomenclature","year":"1995","author":"Mitelman F.","key":"e_1_2_17_22_1"},{"journal-title":"Database of Chromosome Aberrations in Cancer","year":"2005","author":"Mitelman F.","key":"e_1_2_17_23_1"},{"key":"e_1_2_17_24_1","first-page":"1121","article-title":"Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia","volume":"6","author":"Nygren P.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910560517"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(88)90294-7"},{"key":"e_1_2_17_27_1","first-page":"1712","article-title":"Relationship of the growth of leukemic cells in vitro to the outcome of therapy for acute nonlymphocytic leukemia","volume":"44","author":"Preisler H.D.","year":"1984","journal-title":"Cancer Research"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401725"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08782-2"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402883"},{"key":"e_1_2_17_31_1","first-page":"3707","article-title":"Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study\u2010POG 8821","volume":"94","author":"Raimondi S.C.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403253"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1154"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(02)00106-8"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.023"},{"volume-title":"The Basic Science of Oncology","year":"1987","author":"Tannock I.","key":"e_1_2_17_36_1"},{"key":"e_1_2_17_37_1","first-page":"2879","article-title":"Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia","volume":"96","author":"Zwaan C.M.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.9.3352"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05433.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05433.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:38:07Z","timestamp":1697416687000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05433.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05433.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05433.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"2005-04-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}